Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Toronto Dominion Bank

Toronto Dominion Bank boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 202,571 shares of the medical equipment provider’s stock after purchasing an additional 21,079 shares during the quarter. Toronto Dominion Bank’s holdings in Intuitive Surgical were worth $105,734,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Finally, BankPlus Trust Department bought a new position in Intuitive Surgical in the 4th quarter worth approximately $28,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. The trade was a 68.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now owns 6,371 shares in the company, valued at $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock worth $16,865,621 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Truist Financial decreased their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Trading Up 0.6%

NASDAQ ISRG opened at $563.60 on Friday. Intuitive Surgical, Inc. has a 1 year low of $395.60 and a 1 year high of $616.00. The company has a market cap of $202.00 billion, a PE ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70. The stock’s 50-day moving average price is $505.22 and its two-hundred day moving average price is $536.61.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.